why choose us

First received: November 17, 2023

Clinical Trial: Stem Cell Study for Long COVID-19 Neurological Symptoms

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Post-Acute COVID-19 Syndrome

Study Type: INTERVENTIONAL


Official Title: Long COVID: Cord Tissue-Derived Mesenchymal Stromal Cells for Persistent NeuroInflammatory Symptoms

Brief Summary: The purpose of this research study is to test the safety and benefit of a human cord blood derived stem cell infusion as a treatment for individuals with post COVID-19 neurological problems.Participants in the study will have 6 clinic visits over a 12 to 14 mo.period with each visit lasting 2 to 6 hours.Participants will receive 1 stem cell infusion at study visit #3.Participants will have a brain PET and MRI scan at the baseline and 6mo.post-infusion visits.Follow-up safety assessments will be conducted at 6mo.…

Read more